iShares Nasdaq US Biotechnology/BTEC
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About BTEC ETF
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index. The Index measures the performance of companies listed on the NASDAQ Stock Market that are classified as either biotechnology companies or pharmaceutical companies, according to their Industry Classification Benchmark (ICB) and that also meet other eligibility criteria as determined by NASDAQ, Inc. (the Index Provider), including minimum market capitalisation and liquidity requirements.
Ticker
BTEC
Fund name
iShares Nasdaq US Biotechnology
Trading on
LSE
Fund Manager
Blackrock Asset
Share currency
USD
Benchmark
NASDAQ Biotechnology TR
Base currency
USD
BTEC Metrics
$476M
Fund size
0.92
Beta
BTEC Fund Highlights
6.15%
5 year return
Accumulating
Use of income
0.35%
Annual fund charges
0.74%
Vs. other ETFs
0.07%
BTEC Fund Breakdown
Top holdingsSectorsCountries
Amgen
9.15%
Vertex Pharmaceuticals
8.86%
Regeneron Pharmaceuticals
8.31%
Gilead Sciences
7.30%
Moderna
5.69%
Astrazeneca Adr Rep 0.5
4.74%
Biogen
3.42%
Alnylam Pharmaceuticals
1.96%
Illumina
1.73%
Other
47.36%
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
Buy or sell iShares Nasdaq US Biotechnology
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.